3617 related articles for article (PubMed ID: 3882284)
1. Growth of transplantable melanoma and leukaemia and prevention of virus-induced leukaemia in long lived radiation chimeras constructed with unmanipulated bone marrow.
Pierpaoli W
Clin Exp Immunol; 1985 Jan; 59(1):210-6. PubMed ID: 3882284
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic H-2d leads to H-2b irradiation bone marrow chimeras: a) failure to transfer chimerism adoptively and b) immune reactivity of immunocompetent lymphocytes adoptively transferred to chimeras.
Maestroni GJ; Pierpaoli W; Zinkernagel RM
Immunobiology; 1983 May; 164(5):417-29. PubMed ID: 6603414
[TBL] [Abstract][Full Text] [Related]
3. Dominance and persistence of donor marrow in long-lived allogeneic radiation chimeras obtained with unmanipulated bone marrow.
Pierpaoli W; Maestroni GJ
Immunol Lett; 1983 Apr; 6(4):197-202. PubMed ID: 6350170
[TBL] [Abstract][Full Text] [Related]
4. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
5. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
6. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent.
Zinkernagel RM; Sado T; Althage A; Kamisaku H
Eur J Immunol; 1984 Jan; 14(1):14-23. PubMed ID: 6198181
[TBL] [Abstract][Full Text] [Related]
7. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
8. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
9. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
11. Recipient micro-environment does not dictate the Igh-V restriction specificity of T cell suppressor inducer factor (TsiF) from allogeneic bone marrow chimera in mice.
Noguchi M; Ogasawara M; Iwabuchi K; Osgasawara K; Ishihara T; Good RA; Morikawa K; Onoé K
J Immunol; 1985 Oct; 135(4):2557-61. PubMed ID: 2411802
[TBL] [Abstract][Full Text] [Related]
12. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
Ozawa H; Iwaguchi T; Kataoka T
J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
[TBL] [Abstract][Full Text] [Related]
13. Friend leukemia virus-induced leukemogenesis in fully H-2 incompatible C57BL/6-->C3H radiation bone marrow chimeras.
Kitagawa M; Kamisaku H; Sado T; Kasuga T
Leukemia; 1993 Jul; 7(7):1041-6. PubMed ID: 8321019
[TBL] [Abstract][Full Text] [Related]
14. Do donor cells function as veto cells in the induction and maintenance of tolerance across an MHC disparity in mixed lymphoid radiation chimeras?
Pierce GE; Watts LM
Transplantation; 1993 Apr; 55(4):882-7. PubMed ID: 8475564
[TBL] [Abstract][Full Text] [Related]
15. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras.
Pircher H; Baenziger J; Schilham M; Sado T; Kamisaku H; Hengartner H; Zinkernagel RM
Eur J Immunol; 1987 Feb; 17(2):159-66. PubMed ID: 3493906
[TBL] [Abstract][Full Text] [Related]
16. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
Sykes M; Bukhari Z; Sachs DH
Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
[TBL] [Abstract][Full Text] [Related]
18. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
[TBL] [Abstract][Full Text] [Related]
19. Sequential analysis of the virus-immune responder characteristics of thymocytes from F1 leads to parent radiation chimeras.
Korngold R; Doherty PC
Thymus; 1982 May; 4(3):119-33. PubMed ID: 6981232
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
